CHANGING THE STANDARD
CARDIALYTICS™
ADVANCING ARRHYTHMIA CARE
Pristine data
See what you’ve been missing.
Precise Analytics
Real-time, automated, AI-based algorithms physicians can trust.
Powerful Decisions
Comprehensive, clinical decision-making simplified.
EP RECORDING. ENHANCED.
It’s time to upgrade the EP lab.
ECGenius™ System represents an evolution in cardiac signal acquisition, interpretation, and therapy support, creating unprecedented opportunities for the integration of AI-based algorithms.
ABOUT CathVision
CathVision’s mission is to help physicians cure cardiac arrhythmia. Committed to empowering physicians to make more informed clinical decisions in the EP lab, CathVision is redefining the necessity of exceptional cardiac electrical signals to diagnose, characterize and treat the most common heart rhythm disorders. The company is focused on developing electrophysiology solutions centered around an innovative EP recording system and AI-based analytic tools.
CathVision began as a graduate-level clinical research project designed to determine necessary improvements to ablation therapy and was officially launched as a company in 2013 in Denmark. The company’s presence has since expanded to the United States with operations in Minnetonka, Minnesota.
Leadership
Mads Emil Matthiesen
Co-Founder & CEO
Mads Emil Matthiesen
Co-Founder & CEO
- Email:mem@cathvision.com
Rune Ørndrup
Co-Founder
Rune Ørndrup
Co-Founder
Allan Gersfelt-Larsen
VP Engineering
Allan Gersfelt-Larsen
VP Engineering
Board of Directors
Wendy Dittmer
Board Member
Wendy Dittmer
Board Member
Denis Gestin
Board Member
Denis Gestin
Board Member
Meghna Eichelberger
Board Member
Meghna Eichelberger
Board Member
Tonni Bülow-Nielsen
Board Member
Tonni Bülow-Nielsen
Board Member
Magnus Holm
Chairman
Magnus Holm
Chairman